Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.43
-0.02 (-0.37%)
Jun 27, 2025, 4:00 PM - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $245.04 million as of June 27, 2025. Its market cap has decreased by -55.90% in one year.
Market Cap
245.04M
Enterprise Value
-23.57M
1-Year Change
-55.90%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $245.04M, a decrease of -62.75%. That is a compound annual growth rate of -30.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 247.30M | -46.66% |
| Dec 31, 2024 | 463.65M | 4.71% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |